Revision as of 21:59, 23 September 2005 editDuran (talk | contribs)Extended confirmed users1,053 editsNo edit summary← Previous edit | Revision as of 09:18, 19 October 2005 edit undoRufus.cartwright (talk | contribs)37 editsNo edit summaryNext edit → | ||
Line 38: | Line 38: | ||
|} | |} | ||
'''Duloxetine hydrochloride''' (brand name: '''Cymbalta''') is a medically used drug that primarily targets major ] disorders (MDD), pain related to ] ] and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(''S'')-''N''-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of ] (5-hydroxytryptamine, 5-HT) and ] (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors. | '''Duloxetine hydrochloride''' (brand name: '''Cymbalta'''/'''Yentreve''') is a medically used drug that primarily targets major ] disorders (MDD), pain related to ] ] and stress ] (SUI). Known also as LY248686, chemically (+)-(''S'')-''N''-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of ] (5-hydroxytryptamine, 5-HT) and ] (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors. | ||
Furthermore, duloxentine lacks affinity for ] ] within the ]. While there is limited data available regarding the ] profile of duloxetine in humans, its ] is reported to be 10 to 15 hours. | Furthermore, duloxentine lacks affinity for ] ] within the ]. While there is limited data available regarding the ] profile of duloxetine in humans, its ] is reported to be 10 to 15 hours. |
Revision as of 09:18, 19 October 2005
IUPAC chemical name | |
CAS number ? |
ATC code ? |
Chemical formula | C18H19NOS, HCl |
Molecular weight | 333.38 |
Bioavailability | ? |
Metabolism | Hepatic Oxidation |
Elimination half-life | 8-17 hours |
Excretion | 70% in urine, 20% in feces |
Pregnancy category | C (USA) |
Legal status | Prescription only (USA) |
Routes of administration | Oral |
Duloxetine hydrochloride (brand name: Cymbalta/Yentreve) is a medically used drug that primarily targets major depressive disorders (MDD), pain related to diabetic peripheral neuropathy and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(S)-N-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors.
Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. While there is limited data available regarding the pharmacokinetic profile of duloxetine in humans, its half-life is reported to be 10 to 15 hours.
Duloxentine is also approved by the FDA for the treatment of diabetic neuropathy.
External links
- Manufacturer website
- Cymbalta Antidepressant Medication
- Duloxetine - medlineplus.org
This medical treatment–related article is a stub. You can help Misplaced Pages by expanding it. |